CHIEF SCIENTIFIC OFFICER · Structure Therapeutics Inc. · Ordinary Shares
Side
A
Value
—
Shares
43.4K
Price
—
Executed
Mar 19, 2026
Disclosed
Mar 23, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Mar 19 executedMar 23, 2026 disclosed
GPCR · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+9 / 25
No reported dollar value · 23.4% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Lin Xichen filed this Form 4 reporting a grant or award of GPCR on Mar 19, 2026. It became public on Mar 23, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
CHIEF SCIENTIFIC OFFICER
Lin Xichencik:0001962926
Issuer
Structure Therapeutics Inc.cik:0001888886
Revision history · 0
No field has changed since this record was first ingested.
